Q. What product/service do you expect maximum growth in?
A. Contact lenses and gynecological devices.
Q. Is there any pending legislation that might be adverse or favorable to affect earnings projections for Cooper Companies?
A. We always look at changes in Medicare and Medicaid to see how they impact. Sometimes favorably, sometimes unfavorably. The same with any legislation (Federal or State) regarding managed care.
Q. Have you made any significant changes in management within the past year?
A. No changes in operational management. We added Stanley Zinberg, M. D., a prominent academic gynecologist, to our board of directors.
Q. How many shareholders do you have?
A. As of Dec. 31, 1996, Cooper had 3067 shareholders. Approximately 40% is institutionally held with Fidellity the largest holder at about 12%.
Q. Where is your annual report accesible on your web site?
A. Just click on the annual report link at www.coopercos.com.